• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大都市地区13个实验室的肺功能检测结果的可比性。

Comparability of pulmonary function results from 13 laboratories in a metropolitan area.

作者信息

Wanger J, Irvin C

机构信息

National Jewish Center for Immunology & Respiratory Medicine, Denver, CO 80206.

出版信息

Respir Care. 1991 Dec;36(12):1375-82.

PMID:10145587
Abstract

UNLABELLED

We have observed that the results of pulmonary function tests obtained at one site, in general, may not be considered 'acceptable' at another site--in part because of known or suspected variability in equipment and techniques. We sought to document the presence or absence of such variability in our metropolitan area.

METHODS & MATERIALS: We compared the test results from 5 trained healthy subjects (3 men and 2 women) studied in 13 Denver-area pulmonary function laboratories in a randomized order and at approximately the same time of day.

RESULTS

We performed analysis of variance on commonly reported parameters and found no significant difference for FVC (p = 0.11), FEV1 (p = 0.075), FEF25-75% (p = 0.41), and FRC by helium dilution (p = 0.22). However, marked differences between certain sites could be clinically important. In addition, we found a statistically significant difference for DLCO (p less than 0.001) and TLC (p = 0.024). Six different brands of pulmonary function equipment were used by the 13 hospitals, and differences in the number of trials performed, sequence of testing (eg, FRC determinations were sometimes done first, sometimes last), and calculation of the DLCO breath-hold time.

CONCLUSION

We conclude that although the FVC, FEV1, FEF25-75%, and FRC measured by helium dilution were not statistically different in healthy trained subjects in the 13 hospitals studied, clinically important differences may exist. The DLCO and TLC were statistically different. To minimize variability and improve comparability, hospitals in a given area should give consideration to adopting standardized techniques, using comparable equipment, and adopting common reference equations.

摘要

未标注

我们观察到,通常在一个地点获得的肺功能测试结果在另一个地点可能不被视为“可接受”——部分原因是已知或怀疑设备和技术存在差异。我们试图记录在我们所在的大都市地区是否存在这种差异。

方法与材料

我们比较了5名经过训练的健康受试者(3名男性和2名女性)在丹佛地区13家肺功能实验室按照随机顺序且在大致相同的一天中的时间进行研究的测试结果。

结果

我们对常用报告参数进行了方差分析,发现FVC(p = 0.11)、FEV1(p = 0.075)、FEF25 - 75%(p = 0.41)和氦稀释法测定的FRC(p = 0.22)无显著差异。然而,某些地点之间的显著差异在临床上可能很重要。此外,我们发现DLCO(p < 0.001)和TLC(p = 0.024)存在统计学显著差异。13家医院使用了6种不同品牌的肺功能设备,在进行的试验次数、测试顺序(例如,FRC测定有时先进行,有时最后进行)以及DLCO屏气时间的计算方面存在差异。

结论

我们得出结论,尽管在所研究的13家医院中,经过训练的健康受试者通过氦稀释法测量的FVC、FEV1、FEF25 - 75%和FRC在统计学上没有差异,但临床上可能存在重要差异。DLCO和TLC在统计学上存在差异。为了尽量减少差异并提高可比性,特定地区的医院应考虑采用标准化技术、使用可比设备并采用通用参考方程。

相似文献

1
Comparability of pulmonary function results from 13 laboratories in a metropolitan area.大都市地区13个实验室的肺功能检测结果的可比性。
Respir Care. 1991 Dec;36(12):1375-82.
2
[Pulmonary function differences in healthy subjects according to postural changes (author's transl)].健康受试者根据体位变化的肺功能差异(作者译)
Med Clin (Barc). 1979 Aug 15;73(4):149-52.
3
The effect of tiotropium on the pulmonary diffusing capacity.噻托溴铵对肺弥散功能的影响。
Methods Find Exp Clin Pharmacol. 2007 Oct;29(8):535-7. doi: 10.1358/mf.2007.29.8.1116310.
4
Pulmonary function between 40 and 80 years of age.40至80岁之间的肺功能。
J Physiol Pharmacol. 2005 Sep;56 Suppl 4:127-33.
5
[Changes in pulmonary function in SARS patients during the three-year convalescent period].[非典患者三年恢复期肺功能的变化]
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2007 Sep;19(9):536-8.
6
Pulmonary function in adolescents with ataxia telangiectasia.共济失调毛细血管扩张症青少年的肺功能
Pediatr Pulmonol. 2008 Jan;43(1):59-66. doi: 10.1002/ppul.20738.
7
Different diffusing capacity of the lung for carbon monoxide as predictors of respiratory morbidity.不同的肺一氧化碳弥散能力作为呼吸系统疾病的预测指标
Ann Thorac Surg. 2009 Aug;88(2):405-10; discussion 410-1. doi: 10.1016/j.athoracsur.2009.04.015.
8
[Measuring breathing pattern in patients with chronic obstructive pulmonary disease by electrical impedance tomography].[通过电阻抗断层成像技术测量慢性阻塞性肺疾病患者的呼吸模式]
Arch Bronconeumol. 2009 Jul;45(7):320-4. doi: 10.1016/j.arbres.2009.01.013. Epub 2009 Jun 3.
9
Differences in pulmonary function before vs. 1 year after hypofractionated stereotactic radiotherapy for small peripheral lung tumors.小周围型肺癌立体定向放疗前后肺功能的差异对比(立体定向放疗前后对比,放疗采用大分割方式,为期1年) 。 (注:括号内为为使译文更通顺补充的内容) 说明:原英文标题表述不太完整规范,完整准确的翻译需补充部分信息使译文表意更清晰,上述译文括号内是补充的以使读者更好理解的内容。仅供参考,实际应用中可根据文档具体内容和要求灵活调整。 若严格按字面意思翻译为:小周围型肺癌大分割立体定向放疗前与放疗1年后肺功能的差异 。
Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):1003-8. doi: 10.1016/j.ijrobp.2004.12.050.
10
A prospective study of pulmonary function in patients treated with paclitaxel and carboplatin.一项关于接受紫杉醇和卡铂治疗患者肺功能的前瞻性研究。
Cancer. 2002 Jan 15;94(2):452-8. doi: 10.1002/cncr.10182.

引用本文的文献

1
Intersession variability in single-breath diffusing capacity in diabetics without overt lung disease.无明显肺部疾病的糖尿病患者单次呼吸弥散能力的学期间变异性。
Am J Respir Crit Care Med. 2008 Aug 1;178(3):225-32. doi: 10.1164/rccm.200801-090OC. Epub 2008 May 8.